RecruitingNCT06291597
Vaping Adverse Lung and Heart Events Cohort
VapALERT: A Prospective, Exploratory and Adaptive Cohort Study to Identify Symptomatic and Asymptomatic Pulmonary and Cardiovascular Effects of Vaping
Sponsor
Laval University
Enrollment
250 participants
Start Date
Oct 14, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This prospective study assesses the pulmonary and cardiovascular effets of vaping in adult electronic cigarette users with biannual visits and a 5-year follow-up.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age 18 years or older
- Daily electronic cigarette user
- No respiratory infection in the 4 weeks before a visit
Exclusion Criteria1
- Women who are pregnant or breast-feeding.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERVaping
Participants use their vaping products at their own discretion and their intake is monitored via questionnaires.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06291597
Related Trials
Early Detection of Vaping-related Vascular Diseases
NCT054542671 location
TUBSIS 2.0 - Tobacco Use Behavioral Support and Intervention System
NCT075684831 location
Social Media Support Groups for Adolescent Vaping Cessation
NCT075407801 location
Effect of Cannabis on E-Cigarette Use Behavior
NCT066091091 location
The Avenues Study: Dual Use Cessation
NCT064742991 location